Efficacy and Cost Benefit in Filgrastim Biosimilar for Neutropenia in Patients Receiving Chemotherapy: A Single-center, Non-randomized Cohort Study
Not Applicable
Recruiting
- Conditions
- Gynecologic cancer
- Registration Number
- JPRN-UMIN000019110
- Lead Sponsor
- Oita University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) The patients with the bone marrow infiltration 2) Is the patients with hypersensitivity to Patient 3) G-CSF preparation which received radiotherapy within four weeks before registration at chemotherapy initiation 4) The patients who judged that a chief physician was inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method eutropenic (neutrophil count <1,000/mm3) period in each treatment cycle
- Secondary Outcome Measures
Name Time Method